$SUI buy more

【Sunshine Biopharma’s board authorizes up to a 1:20 reverse stock split】

According to Reuters, Sunshine Biopharma’s board has authorized a reverse stock split of up to 1:20 of its common stock.

Entry: 0.7033-0.7118
Take profit: 0.7265
Stop loss: 0.688

Let’s talk technicals for a couple more lines: On the 1-hour chart, the MACD forms a golden cross above the zero axis, the DIFF has just turned, and the short-term bias is bullish—no problem there; the RSI has climbed out of the oversold zone and still has room to move higher; when volume pulls back it contracts, and when the rebound comes it expands—classic signs of capital accumulation.

Honestly, I’ve been watching this level for quite a while. The price has been pulling back all the way from above down to around 0.7075, right a bit above the EMA20 (0.7). This spot isn’t chosen at random—EMA20 is the lifeline of the short-term trend. The fact that the price retraces and doesn’t break below it means the bulls haven’t given up yet. This is a typical “pullback confirmation” pattern.

The take-profit level wasn’t picked on a whim. It’s calculated from the 1-hour chart’s Bollinger upper band and the prior consolidation high. 0.7265 lands right at the intersection of two resistance zones. By then, profit-taking from longs and trapped-position unwind orders will both come in to sell, so it’s hard to push through in one go. Better to lock in gains first.

0.688 is a few points lower than the previous low, leaving a bit of buffer so you’re not taken out by a single wick. That kind of stop-out is the most irritating. The stop-loss distance is about 2.8%, and the first take-profit target is about 2.7%, for a risk-reward of 1.0:1. Even if the win rate is only half, you can still make money. The math checks out.

🔴Click here to place an order 👉👉👉 $SUI